Publications

Journal Articles

  1. & Review of the epidemiology of burn injuries in Ethiopia; implications for study design and prevention. Burns Open 3(3), 75-82.
  2. & The malaria testing and treatment landscape in Kenya: results from a nationally representative survey among the public and private sector in 2016. Malaria Journal 16(1)
  3. & When it just won’t go away: oral artemisinin monotherapy in Nigeria, threatening lives, threatening progress. Malaria Journal 16(1)
  4. & Private sector role, readiness and performance for malaria case management in Uganda, 2015. Malaria Journal 16(1)
  5. & Do anti-malarials in Africa meet quality standards? The market penetration of non quality-assured artemisinin combination therapy in eight African countries. Malaria Journal 16(1)
  6. & Testing times: trends in availability, price, and market share of malaria diagnostics in the public and private healthcare sector across eight sub-Saharan African countries from 2009 to 2015. Malaria Journal 16(1)
  7. & Private sector opportunities and threats to achieving malaria elimination in the Greater Mekong Subregion: results from malaria outlet surveys in Cambodia, the Lao PDR, Myanmar, and Thailand. Malaria Journal 16(1)
  8. & What happened to anti-malarial markets after the Affordable Medicines Facility-malaria pilot? Trends in ACT availability, price and market share from five African countries under continuation of the private sector co-payment mechanism. Malaria Journal 16(1)
  9. & Insights into the availability and distribution of oral artemisinin monotherapy in Myanmar: evidence from a nationally representative outlet survey. Malaria Journal 16(1)
  10. & Evidence on anti-malarial and diagnostic markets in Cambodia to guide malaria elimination strategies and policies. Malaria Journal 16(1)
  11. & Anti-malarial landscape in Myanmar: results from a nationally representative survey among community health workers and the private sector outlets in 2015/2016. Malaria Journal 16(1)
  12. & The malaria testing and treatment landscape in mainland Tanzania, 2016. Malaria Journal 16(1)
  13. & Targets and Mechanisms Associated with Protection from Severe Plasmodium falciparum Malaria in Kenyan Children. Infection and Immunity 84(4), 950-963.
  14. & Identifying children with excess malaria episodes after adjusting for variation in exposure: identification from a longitudinal study using statistical count models. BMC Medicine 13(1)
  15. & New antigens for a multicomponent blood-stage malaria vaccine. Science Translational Medicine 6(247), 247ra102-247ra102.
  16. & Plasmodium falciparum Infection Patterns Since Birth and Risk of Severe Malaria: A Nested Case-Control Study in Children on the Coast of Kenya. PLoS ONE 8(2), e56032
  17. & Estimating Individual Exposure to Malaria Using Local Prevalence of Malaria Infection in the Field. PLoS ONE 7(3), e32929
  18. Correction: Stable and Unstable Malaria Hotspots in Longitudinal Cohort Studies in Kenya..
  19. Correction: Defining Clinical Malaria: The Specificity and Incidence of Endpoints from Active and Passive Surveillance of Children in Rural Kenya..
  20. & Clearance of Asymptomatic P. falciparum Infections Interacts with the Number of Clones to Predict the Risk of Subsequent Malaria in Kenyan Children. PLoS ONE 6(2), e16940
  21. Correction: Interactions between Age and ITN Use Determine the Risk of Febrile Malaria in Children..
  22. & Defining Clinical Malaria: The Specificity and Incidence of Endpoints from Active and Passive Surveillance of Children in Rural Kenya. PLoS ONE 5(12), e15569
  23. & Stable and Unstable Malaria Hotspots in Longitudinal Cohort Studies in Kenya. PLoS Medicine 7(7), e1000304
  24. & Interactions between Age and ITN Use Determine the Risk of Febrile Malaria in Children. PLoS ONE 4(12), e8321
  25. & Extended Follow-Up Following a Phase 2b Randomized Trial of the Candidate Malaria Vaccines FP9 ME-TRAP and MVA ME-TRAP among Children in Kenya. PLoS ONE 2(8), e707
  26. & Defining Childhood Severe Falciparum Malaria for Intervention Studies. PLoS Medicine 4(8), e251
  27. & The Haptoglobin 2-2 Genotype Is Associated with a Reduced Incidence of Plasmodium falciparum Malaria in Children on the Coast of Kenya. Clinical Infectious Diseases 44(6), 802-809.
  28. Explaining discrepancies in reproductive health indicators from population-based surveys and exit surveys: a case from Rwanda. Health Policy and Planning 16(2), 137-143.